Aumake Limited (ASX: AUK) has announced a comprehensive Aumake business restructure and rebrand, proposing to transition to Xenitra Limited (ASX:XEN) following shareholder approval. The transformation combines strategic refocusing on profitable growth with structural simplification, targeting over $1.1 million in annualised cost savings across FY26 and FY27. The company has outlined three strategic pillars designed to shift from its tourism-era origins to a China-centric sales and marketing platform serving nutritional and over-the-counter medicine markets.
Three strategic pillars targeting profitable growth
The company’s revised strategic framework centres on three distinct growth areas, each designed to leverage existing platform capabilities while expanding into higher-margin product categories:
- Enhance the profitability of the Nutritionals Market by diversifying into Infant and Adult Specialty Nutrition Products, Medical Foods, Vitamins, Minerals and Supplements (VMS), Natural Medicines and Nutraceuticals, whilst increasing sales velocity through efficient working capital deployment.
- Grow the new OTC Medicine Market through the launch of 6 online stores across key Chinese ecommerce platforms, seeking brand partnerships via sub-distribution and licensing arrangements for high-value products in high demand need states, with value-adding acquisitions considered where they support licence procurement and market expansion.
- Drive further value from Sales and Marketing platforms by codifying business processes through technology-driven solutions, aggressively expanding brand partnerships across Nutritional and OTC Medicines categories, and exploring adjacent categories in health, wellness, personal care and FMCG products that align with the established customer base through licensing, strategic partnerships and acquisitions.
The strategy positions the company to target higher-margin sectors whilst leveraging its existing commerce infrastructure, representing a capital-efficient approach to revenue growth through platform optimisation rather than fixed asset expansion.
When big ASX news breaks, our subscribers know first
Cost savings and structural simplification
The Aumake business restructure and rebrand delivers material cost reductions through two structural improvements. The Australian-based Executive Director role will not be replaced, yielding savings exceeding $600,000 per annum in salary, fringe benefits, travel and entertainment costs based on historical expenditure. Staff streamlining aims to deliver over $500,000 in annualised head office cost savings, with the Australian executive team limited to corporate support functions covering Finance, Administration and IT.
The company will transition to an asset-light virtual Australian office model, eliminating rental and warehousing costs domestically. Board members will assume direct oversight of key functions: Anthony Noble (Corporate Affairs), Zoran Grujic (Financial Control), Carl Hagon (Legal and Compliance), and Alex Li (China Market Relations and ex-China trading opportunities).
Additionally, the company has resolved to exit two joint venture entities, 168 Express Pty Ltd and Newera Pty Ltd, which it has determined are not commercially feasible due to historical contract price frameworks, market price evolution for envisaged goods, and associated operating costs. The company intends to divest or wind up these entities, which have no material revenues, as soon as possible. Following divestment or wind-up, all future business activities will be undertaken through 100% owned subsidiaries, simplifying corporate structure and ensuring alignment between capital allocation and shareholder returns.
| Cost Reduction Area | Action | Estimated Annual Savings |
|---|---|---|
| Executive Director Role | Not replaced | >$600,000 |
| Head Office Staff | Streamlined | >$500,000 |
| Office/Warehouse | Virtual model | Rental costs eliminated |
| Joint Ventures | Exit/wind up | Overhead removed |
The combined annualised savings exceed $1.1 million, directly improving the path to profitability for the small-cap restructure whilst reducing administrative and compliance costs associated with the simplified corporate structure.
Leadership and operational structure
Tracy Zhao has been appointed as Head of China, based in Hong Kong, retaining operational and managerial control of the Hong Kong and Hangzhou-based business divisions. This centralised China leadership structure operates alongside the board’s direct functional oversight model:
- Anthony Noble: Corporate Affairs
- Zoran Grujic: Financial Control
- Carl Hagon: Legal and Compliance
- Alex Li: China Market Relations and ex-China trading opportunities
The restructured governance framework supports the asset-light, low-cost operational model by concentrating China market execution under dedicated regional leadership whilst board members cover essential corporate functions, reducing fixed overhead costs whilst maintaining strategic oversight and market connectivity.
What is a corporate restructure and why does it matter for investors?
Corporate restructures involve reorganising a company’s operations, cost base, or strategic focus to improve financial performance. Small-cap restructures typically occur when historical business models no longer align with market conditions, requiring companies to eliminate unprofitable activities and concentrate resources on higher-margin opportunities.
Successful restructures can create shareholder value by reducing fixed costs, simplifying operational complexity, and refocusing capital allocation toward activities with clearer paths to profitability. The announced measures address legacy structural issues by exiting joint ventures with no material revenues, eliminating redundant overhead, and concentrating the business on China market sales and marketing activities where management capabilities are strongest.
For investors, restructures represent both risk and opportunity. Execution uncertainty remains until announced cost savings materialise in reported financials and the focused strategy delivers measurable revenue growth. Key metrics to monitor include whether the $1.1 million in annualised savings flow through to improved profitability, whether the six planned OTC online stores launch on schedule, and whether the simplified structure improves working capital efficiency as management suggests.
The transition from tourism-focused origins to a China-centric platform business reflects broader sector shifts following COVID-19, with the company now positioned to leverage codified processes and digital infrastructure rather than physical retail presence.
Chairman outlines path forward
Chairman Dr Anthony Noble emphasised the company’s refocusing on activities aligned with defined strategy and sustainable competitive advantages, acknowledging historical strategic drift that led to pursuits beyond management’s core capabilities.
Dr Anthony Noble, Chairman
“The Company has a strong sales and marketing capability, an enviable commerce platform and a very capable senior management team in terms of business development skills. There has been a lack of strategic focus in the past that has led to several activities being pursued for which management at the time, did not have the depth of knowledge or managerial experience to fully execute. Moving ahead, the Company will be focussed on activities that align with our defined strategy and activities that can drive enhanced value from these activities, or that can build IP and drive sustainable competitive advantages around those core activities. We are also committed to improving the cadence and clarity of our communication to the market on delivering against our strategic goals.”
Noble highlighted the company’s capacity to utilise working capital efficiently, noting sales performance achieved in prior reporting periods despite holding low cash balances. He stated the board has addressed deficiencies in business understandability and transparency through structural simplification and the joint venture wind-up or divestment, with the proportion of management cost relative to revenue generation now well balanced across business units.
The board has taken an active role in implementing leaner, simpler management and financial systems, with oversight of streamlined system implementation planned over the coming quarter. Noble noted the company has recognised meaningful cost savings over 2025 through business streamlining processes ongoing since April, which will improve profitability.
The chairman’s commentary signals board-level commitment to accountability and clearer investor communication, often a positive indicator for small-cap governance where execution transparency becomes critical during transformation periods.
The next major ASX story will hit our subscribers first
Next steps for Aumake shareholders
The Aumake business restructure and rebrand to Xenitra Limited (ASX:XEN) requires shareholder approval, with the board having recommended the change to reflect the company’s evolution toward bi-directional trade across Asia Pacific markets and its focus on codifying and digitising the value chain within its platform business. The company will look beyond the Australian market for supply partnerships whilst maintaining its China market focus.
Immediate operational priorities include:
- Wind-up or divestment of 168 Express Pty Ltd and Newera Pty Ltd joint ventures as soon as possible
- Launch of 6 OTC online stores across Chinese ecommerce platforms
- Implementation of streamlined management and financial systems over the coming quarter
- Transition to virtual Australian office model with associated cost reductions
Near-term catalysts for investors include confirmation of joint venture exits, evidence of the $1.1 million annualised cost savings flowing through to financial results, progress on OTC store launches, and the shareholder vote on the corporate rebrand. Each milestone provides measurable checkpoints against which the restructure thesis can be assessed, with the balance of FY26 and FY27 serving as the critical execution window for the three strategic pillars targeting profitable growth.
The simplified corporate structure through 100% owned subsidiaries aims to provide greater transparency on cash utilisation, profitability and cost allocation across operating businesses, addressing historical deficiencies in financial clarity that the board has acknowledged. Management’s track record in delivering sales performance with limited working capital will be tested as the focused strategy targets higher-margin nutritional and OTC medicine categories through platform leverage rather than capital-intensive expansion.
Get Consumer Stock News Before the Market Moves
Join 20,000+ investors receiving FREE breaking ASX Consumer news within minutes of release, complete with in-depth analysis. StockWire X delivers alerts the moment announcements drop, giving you the edge on restructures, strategic pivots and material updates. Click the “Free Alerts” button to start receiving real-time coverage.
